ABOUT THE EXPERTS

Screen Shot 2020-03-21 at 14.56.35.png

PROFESSOR BILL KEEVIL

Professor

Bill is Professor of Environmental Healthcare and Heads the Microbiology Group in Biological Sciences at University of Southampton, working on rapid detection of infectious agents in the natural and built environments, and developing decontamination strategies for antimicrobial resistant bacteria, biofilms, viruses and prions. He formerly worked as Head of Microbial Technology Department and Scientific Leader at CAMR, Porton Down where he developed the continuous culture biofilm fermenter, and artificial urine and saliva media for biofilm studies.

 

He gave the first description of 3D polymicrobial biofilm structures and initiated his work on antimicrobial copper in drinking water systems. He moved to University of Southampton as Director of the Environmental Healthcare Unit in 2001 where he elucidated the mechanisms of antimicrobial copper touch surfaces and was co-inventor of the EDIC microscope for high resolution detection of bacteria, biofilms and CJD prions on complex surfaces. He is a Fellow of the American Academy of Microbiology and former Scientific Advisor to the House of Commons Science & Technology Committee. His 30 minute presentation is linked below that he made at the 1st International Symposium on antimicrobial copper in Spain.

Screen Shot 2020-03-21 at 14.56.22.png

PROFESSOR MICHAEL SCHMIDT

Professor

Professor Michael Schmidt is Professor and Vice Chairman of Microbiology and Immunology at The Medical University of South Carolina, currently, he is developing a series of comprehensive multi-center clinical trials that will evaluate the world’s first continuously active and non-leaching antimicrobial gloves for use in healthcare in order to assess their utility in limiting the acquisition of healthcare associated infections (HAI). This work directly compliments his efforts in leading an inter-institutional/ interdisciplinary team of professionals investigating the role that microbes associated with objects present in the built clinical environments play in this 150 billion dollar problem facing US healthcare.

 

Here in concert with a group of infectious disease specialists, infection control professionals, architects and engineers they are building on the success of a previous multi-center clinical trial where they established that by controlling burden in the built clinical environment through the introduction of the limited and targeted placement of solid copper alloys, they were able to significantly reduce HAI acquisition rates by 58%. Much of the basic science work from the evaluation of the antimicrobial properties of copper led to recent efforts into the realm of dental materials where he with clinical colleagues appreciated the role that copper-iodide nanoparticles might serve in continuously limiting biofilm activity associated with dental restorations resulting in improved outcomes secondary to longevity enhancements of the dental materials in the oral environment.


He serves as an invited reviewer for the literature of his field, serving on the Editorial Boards for the Journal of Applied and Environmental Microbiology (AEM) and the International Editorial Board for Infection Prevention in Practice (IPIP) for the Healthcare Infection Society of England. He presently serves as regular contributor to the internationally recognized podcast This Week In Microbiology (TWiM).

Watch the Presentations from the 2019 1st International Symposium on antimicrobial copper in Spain. Click on the names below to view the presentations on YouTube:

 

© 2020 Coronasafe Ltd Registered Company:12541671